Browse Articles
Discover research articles across all indexed journals
A retrospective case-control study of reasons for referral, main distresses, and goals of care among HIV/AIDS and cancer patients in palliative care
Impact analysis assessment of UAS collision with a human body
This study investigates the safety risks of Unmanned Aerial System (UAS) collisions with humans, focusing on impact dynamics through controlled crash testing. Utilizing a custom-designed drop mechanism, 49 impact tests were conducted on a Hybrid III anthropomorphic test device at various velocities and kinetic energies (7–24 m/s and 1–280 J). Tested UASs included a range of designs and weights (20 g to over 1 kg). Results demonstrated limitations in using kinetic energy models and peak head acceleration for injury prediction. The Head Injury Criterion showed greater consistency, reflecting the temporal profile of impacts. Findings revealed that UAS structural fragility reduces energy transfer at higher impacts through deformation and fracturing. This work underscores the need for improved testing protocols and nuanced safety standards.
Non-invasive liver fibrosis markers are increased in obese individuals with non-alcoholic fatty liver disease and the metabolic syndrome
Drug regulatory affairs under focus: Knowledge and perceptions among pharmacists and pharmacy students
Objectives Pharmaceutical product development, registration, and post-marketing surveillance are the main concerns of the Regulatory Affairs (RA) profession in regulated pharmaceutical industries. The RA assumes a pivotal role in ensuring product quality, patient safety, and drug efficacy and constitutes a vital part of the pharmaceutical industry. The current study aims to evaluate the knowledge and understanding of the concept of RA and Drug Registration (DR) among pharmacists and pharmacy students in Jordan. Methods A cross-sectional study was conducted targeting pharmacists in different sectors and pharmacy students to assess knowledge and perceptions of RA and DR in Jordan. The participants were invited to participate by sending the survey link through social media platforms (WhatsApp). Results A total of 411 participants completed the study survey. Among the study participants, 193 were pharmacists (47.0%), while the rest were pharmacy students. The majority indicated that they had never taken a course related to RA during their undergraduate studies (77.4%). About half of the participants lacked awareness of RA personnel responsibilities with most of the participants agreeing that workshops, lectures, and training are required. Interpretation of results and conclusion This study aims to elevate Jordanian pharmacists’ awareness by focusing the efforts on young pharmacists and pharmacy students. This can be achieved by implementing RA courses within the pharmacy curricula and upholding the role of the regulatory bodies in Jordan.
Green and sustainable synthesis of MWCNT@g-C₃N₄@Ag photocatalyst from PET for efficient wastewater treatment
Nomogram for predicting olfactory disorder in obstructive sleep apnea: A retrospective study based on a multicenter database
Objective Obstructive sleep apnea (OSA) increases the risk of olfactory disorder (OD), which may serve as an early warning of adverse health consequences. In this study, we aimed to develop and validate a nomogram for early detection of OD in patients with OSA. Methods We retrospectively analyzed 125 patients with OSA at Beijing Anzhen Hospital for the development and internal validation of the nomogram. For external validation, 30 patients with OSA were recruited from the Air Force Medical Center. The included participants completed polysomnography (PSG) and the Sniffin’ Sticks test. Patients with OSA were divided into two groups: OSA with OD and OSA without OD. Results The nomogram included age, sex, and time spent with oxygen saturation below 90%. The area under the receiver operating characteristic curve of the nomogram was 0.814 (95% confidence interval [CI]: 0.673–0.955) for the internal validation group, and 0.778 (95% CI: 0.601–0.955) for the external validation group. The nomogram exhibited excellent discrimination and calibration, showing substantial benefits in clinical applications. Conclusion The present nomogram developed based on clinical characteristics and PSG features can serve as a convenient tool for clinicians to detect OD in OSA, aiding in patient stratification and personalized treatment.
Accelerators of chronic hepatitis B fibrosis cirrhosis CCND1 gene expression and promoter hypomethylation
Association of a CHEK2 somatic variant with tumor microenvironment calprotectin expression predicts platinum resistance in a small cohort of ovarian carcinoma
High-grade serous ovarian cancer (HGSOC) low overall survival rate is often attributed to platinum resistance. Recent studies suggest that the tumor associated-microenvironment (TME) is a determining factor in malignant tumor progression and DNA damage plays a crucial role in this process. Here, we sought to identify platinum resistance biomarkers associating the TME immune profile and the mutational landscape of the homologous repair pathway genes with the HGSOC patients prognosis and response to chemotherapy. Using a decision tree classifier approach, we found that platinum resistant (PR) patients were characterized by the presence of a novel deep intronic variant, the CHEK2 c.319+ 3943A > T, and higher L1 expression (p = 0.016), (100% accuracy). Chek2 protein is an important component of DNA repair and L1, also known as calprotectin, is one component of the neutrophil extracellular traps (NETs) during inflammation, previously suggested as a key contributor to the metastatic process in HGSOC. Also, PD-L2 levels were significantly higher in PR patients positive for this CHEK2 variant (p = 0.048), underscoring the need to explore its potential therapeutic role for this cancer. Our results suggest an interplay between TME and DNA repair variants that results in a multifactorial nature of HGSOC resistance to platinum chemotherapy.
Expression of prestige through authentic pride, not dominance through hubristic pride, promotes fairness in ultimatum bargaining
Systemic immune-inflammation index is associated with clinical outcome of acute ischemic stroke patients after intravenous thrombolysis treatment
Introduction The systemic immune-inflammation index (SII) has been proven to predict the outcome in cancerous and non-cancerous diseases. We aimed to investigate the relationship between SII and other inflammatory markers and the prognosis in patients receiving intravenous thrombolysis (IVT). Methods Acute ischemic stroke patients treated with IVT were collected retrospectively. SII, neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were constructed based on admission blood testing. Favorable outcome was defined as modified Rankin Scale of less than or equal to 2 at 90 days. In addition to outcome, cerebral edema was analyzed. The severity of brain edema was graded into three levels according to Thrombolysis in Stroke-Monitoring Study. Malignant cerebral edema (MCE) was defined as brain edema with midline shift. Results 278 patients were included. 140 (50.4%) achieved favorable outcome, 35 (12.6%) developed MCE. In patients with favorable outcomes, the levels of SII, NLR and PLR were lower compared to those with unfavorable outcomes [422.33 (258.69-624.68) vs 1269.83 (750.82-2497.22), p < 0.001; 2.73 (1.68-4.40) vs 4.76 (2.59-7.72), p < 0.001; 92.98 (62.35-126.24) vs 115.64 (85.51-179.04), p < 0.001]. The area under the Receiver Operating Characteristic curve was 0.698 for SII (95% CI = 0.637-0.760, p < 0.001), 0.694 for NLR (95% CI = 0.632-0.756, p < 0.001), 0.643 for PLR (95% CI = 0.579-0.707, p < 0.001). The optimal cut-off values were 652.73 for SII (sensitivity 0.572, specificity 0.786), 3.57 for NLR (sensitivity 0.659, specificity 0.693), 127.01 for PLR (sensitivity 0.457, specificity 0.757). Conclusions An early increase in SII levels was related to 3 months of unfavorable outcomes in AIS patients after IVT. However, it is not associated with malignant edema.
Exploring the effects of paclitaxel-loaded zein nanoparticles on human ovarian carcinoma cells
Genomics yields biological and phenotypic insights into bipolar disorder
High-throughput 96-well plate-based porcine antibody isolation protocol
For decades, scientists have used column chromatography to purify an array of analytes. The same chromatography system has also been deployed for the isolation and purification of antibodies to increase sensitivity and specificity of detection assays such as western blot, enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry. However, even with the combination of these modalities the detection of specific antibodies developed in response to treatment, like vaccination, remains difficult due to physiological differences among species, sample types evaluated, and differing physiological states. Therefore, we developed a high-throughput antibody isolation protocol to measure influenza-specific antibodies in pregnant and lactating pigs, because the samples, in particular serum, milk and colostrum, contain components that cause high background. We developed a high-throughput 96-well plate-based method using a modified column chromatography technique to specifically isolate swine immunoglobulin (Ig) isotypes. This method utilizes isotype-specific reagents to isolate the IgG and IgA antibody isotypes from various fluids collected at multiple time points from individual animals following immunization. After sample processing and antibody isolation, the results showed a rapid and consistent yield of specific IgG and IgA, with comparable outcomes between single-column chromatography and our 96-well plate system, the latter offering a time-saving advantage. Specifically, the standard single-column chromatography required 2 to 3 hours to isolate 12 samples, whereas our method enabled the isolation of 192 samples in just 8 to 9 hours making this the ideal method for an immunogenicity study utilizing a variety of animal samples from multiple timepoints.
Impact assessment of photovoltaic and wind energy integration on low voltage distribution networks in Tunisia
Methodological considerations for assessing elder mistreatment of older adults with cognitive impairment: A scoping review protocol
Elder mistreatment (EM) of older persons with cognitive impairment is thought to be grossly underestimated in part due to communication barriers experienced by victims and a lack of consistent screening and reporting, which can skew current understandings of this problem. To improve EM risk and prevalence screening in relation to cognitive impairment, it is important to understand specific approaches for implementing assessment tools and interventions for members of this population. Accordingly, this scoping review (OSF registration osf.io/759k3) will identify, summarize, and compare methodological considerations adopted in studies assessing EM risk and occurrence among older persons with varying degrees of cognitive impairment. Through mapping out existing strategies and approaches used to develop, test, and implement EM screening tools or interventions, this review will outline previously identified recommendations and challenges pertinent to future EM assessment, reduction, and prevention efforts. We will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines and apply the Arksey and O’Malley (2005) scoping review framework. We will identify relevant studies by comprehensively searching electronic databases, including Ovid (Medline), Cumulative Index of Nursing and Allied Health Literature (CINAHL), Cochrane Trials (CENTRAL), and Elsevier’s Scopus. Reference lists of included studies will also be examined. For article selection, we will use Covidence software to guide a two-step process of title/abstract and full article screening, which will allow us to identify eligible studies based on our inclusion and exclusion criteria that follows the Study Design, Data, Methods, Outcomes (SDMO) framework. A standardized data extraction tool will be used to collect information related to authors, year of publication, research objectives, sample and study design characteristics, measures, analysis, outcomes, limitations, and study conclusions and implications related to cognition. Data will be analyzed using a thematic approach and presented through the reporting of descriptive statistics and summaries.
Fall recognition using a three stream spatio temporal GCN model with adaptive feature aggregation
A crucial role for the cortical amygdala in shaping social encounters
Assessing concentration in the monoclonal antibody innovation market: A patent-based study
BACKGROUND Monoclonal antibodies (mAbs) are revolutionizing healthcare treatments due to their high efficacy and relative safety, despite their cost. Since they first appeared in the late 1980s, a rapidly growing market has developed. OBJECTIVE This study aims to analyze concentration levels in the market for mAb innovations through a quantitative patent analysis. Data were analyzed using traditional concentration indicators such as the Herfindahl-Hirschman Index and Concentration Ratio, as well as linear regression and kernel density graphs to evaluate innovation and global technology dissemination strategies. The starting point was patents associated with mAbs registered by the FDA and identified in the IQVIA database up until 2019, and supplemented by data from The Antibody Society, Purple Book, Orange Book, and FDA. RESULTS Our findings indicate that the market for mAb innovations is moderately concentrated for general patents and unconcentrated for priority patents. However, it is significantly more concentrated than the market for chemical drug innovations. The mAb patent families tend to generate more progeny patents, although they are deposited in fewer countries. Chemical drug patents spread faster. Some companies seem to be central to the development of mAbs worldwide, including Roche, PDL, City of Hope, and Celltech. Other important players in the mAb innovation market are AbbVie, Amgen, Novartis, GSK, Biogen, BMS, Regeneron, J&J, and AstraZeneca. The most relevant patents in the analysis are associated with methods and procedures to obtain mAbs, not with molecules themselves. CONCLUSION The concentration in the mAb innovation market is higher than the concentration in the market for chemical drugs innovations. Our findings also indicate that expertise in mAbs development and production is concentrated in a few countries. Additionally, our study identified that a few key players from high-income countries are driving innovation in the mAb market.